Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma

被引：5
|
作者：
Kourelis, T. V. [1 ]
Kumar, S. K. [1 ]
Srivastava, G. [1 ]
Gertz, M. A. [1 ]
Lacy, M. Q. [1 ]
Buadi, F. K. [1 ]
Kyle, R. A. [1 ]
Dispenzieri, A. [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55902 USA
来源：
LEUKEMIA | 2014年 / 28卷 / 02期
关键词：
POOR-PROGNOSIS; THERAPY;
D O I：
10.1038/leu.2013.300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：455 / 457
页数：4
相关论文
共 50 条
  • [41] Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    LeBlanc, Richard
    Baljevic, Muhamed
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Venner, Christopher P.
    Gasparetto, Cristina
    Chen, Christine I.
    Lipe, Brea
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    Callander, Natalie S.
    Bensinger, William I.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Zhou, Tianjun
    Kazuharu, Kai
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Schiller, Gary J.
    [J]. BLOOD, 2020, 136
  • [42] DEEP AND DURABLE RESPONSES WITH WEEKLY IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: LONG-TERM FOLLOW-UP OF PATIENTS WHO DID NOT UNDERGO SCT
    Kumar, S.
    Berdeja, J.
    Niesvizky, R.
    Lonial, S.
    Laubach, J.
    Hamadani, M.
    Stewart, A. K.
    Hari, P.
    Roy, V.
    Vescio, R.
    Kaufman, J.
    Berg, D.
    Liao, E.
    Rajkumar, V.
    Richardson, P.
    [J]. HAEMATOLOGICA, 2017, 102 : 142 - +
  • [43] Efficacy and Safety Profile of Long-Term Exposure to Lenalidomide in Patients With Recurrent Multiple Myeloma
    Fouquet, Guillemette
    Tardy, Stephanie
    Demarquette, Helene
    Bonnet, Sarah
    Gay, Julie
    Debarri, Houria
    Herbaux, Charles
    Guidez, Stephanie
    Michel, Jessica
    Perrot, Aurore
    Serrier, Caroline
    Miljkovic, Darko
    Loiseau, Herve Avet
    Facon, Thierry
    Hulin, Cyrille
    Leleu, Xavier
    [J]. CANCER, 2013, 119 (20) : 3680 - 3686
  • [44] BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma
    Rossi, Adriana
    Mark, Tomer
    Jayabalan, David
    Christos, Paul
    Zafar, Faiza
    Pekle, Karen
    Pearse, Roger
    Chen-Kiang, Selina
    Coleman, Morton
    Niesvizky, Ruben
    [J]. BLOOD, 2013, 121 (11) : 1982 - 1985
  • [45] Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide
    Kobayashi, Takahiro
    Miura, Masatomo
    Niioka, Takenori
    Fujioka, Yuki
    Abumiya, Maiko
    Yoshioka, Tomoko
    Kameoka, Yoshihiro
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    [J]. BLOOD, 2017, 130
  • [46] Long-term response and response patterns to antiepileptic drugs in patients with newly diagnosed epilepsy
    Li, Yudan
    Li Xia
    Wang, Yuxuan
    Li, Rong
    Li, Jingyi
    Pan, Songqing
    [J]. EPILEPSY & BEHAVIOR, 2021, 124
  • [47] Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma
    Schavgoulidze, Anais
    Lauwers-Cances, Valerie
    Perrot, Aurore
    Cazaubiel, Titouan
    Chretien, Marie-Lorraine
    Moreau, Philippe
    Facon, Thierry
    Leleu, Xavier
    Karlin, Lionel
    Stoppa, Anne-Marie
    Decaux, Olivier
    Belhadj, Karim
    Arnulf, Bertrand
    Mohty, Mohamad
    Mariette, Clara
    Fohrer-Sonntag, Cecile
    Lenain, Pascal
    Marolleau, Jean-Pierre
    Tiab, Mourad
    Araujo, Carla
    Orsini-Piocelle, Frederique
    Jaccard, Arnaud
    Roussel, Murielle
    Benboubker, Lotfi
    Eveillard, Jean-Richard
    Dib, Mamoun
    Divoux, Marion
    Attal, Michel
    Avet-Loiseau, Herve
    Corre, Jill
    [J]. HAEMATOLOGICA, 2023, 108 (05) : 1374 - 1384
  • [48] Immunological Consequences of Lenalidomide with and without Dexamethasone in Newly Diagnosed Multiple Myeloma
    Kloeber, Jake A.
    Kimlinger, Teresa K.
    Haug, Jessica L.
    Henderson, Kimberly J.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    [J]. BLOOD, 2019, 134
  • [49] Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis
    Baz, Rachid
    Patel, Mehul
    Finley-Oliver, Elizabeth
    Lebovic, Daniel
    Hussein, Mohamad A.
    Miller, Kena C.
    Wood, Margaret
    Sher, Taimur
    Lee, Kelvin
    Chanan-Khan, Asher A.
    [J]. LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1015 - 1019
  • [50] Association of Serum Free Light Chain Level with Long-Term Kidney Function in Patients with Newly Diagnosed Multiple Myeloma
    Lopedote, Paolo
    Alhaddad, Juliano
    Zheng, Guoliang
    Abualshar, Mu'taz
    Ghanta, Shree
    Kozyreva, Olga
    Jaber, Bertrand L.
    [J]. NEPHRON, 2024, 148 (06) : 399 - 407
12345